Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameVITEK GRAM POSITIVE AST FOR MOXIFLOXACIN
Classification Namesusceptibility test cards, antimicrobial
Generic Nameantimicrobial susceptibility test system-short incubation
Regulation Number866.1640
ApplicantBIOMERIEUX, INC.
PMA NumberN50510
Supplement NumberS142
Date Received12/18/2000
Decision Date05/30/2001
Product Code
LTW[ Registered Establishments with LTW ]
Advisory Committee Microbiology
Supplement Typenormal 180 day track
Supplement Reason other
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the addition to the vitek. Gram positive susceptibility panels, the antibiotic moxifloxacin at equivalent concentrations of 1, 2, and 4 mcg/ml. The device will be marketed under the trade name vitek. Gram positive susceptibility (gps) card for moxifloxacin, and is indicated for use in vitek. Gram positive susceptibility test cards for the susceptibility testing of staphylococcus aureus isolates to moxifloxacin in the range of <=0. 25 to >=8 mcg/ml.
-
-